TAK, US8740602052

Takeda stock gains 0.82 percent as spinout reports Phase 3 result

Published on 10/08/2026 at 09:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Takeda stock stood at JPY 5,766 on October 7 after a 0.82 percent gain on the Tokyo Stock Exchange. Its spinout cut Parkinson's off time by 0.61 hours in Phase 3.

TAK, US8740602052, Illustration mit AI erstellt.

Takeda stock (ISIN US8740602052) rose 0.82 percent to JPY 5,766 on the Tokyo Stock Exchange at 3:30 p.m. JST on October 7, 2026. The fresh company-related signal came from Cerevance, a Takeda spinout, which reported a Phase 3 Parkinson's result on October 7.

Spinout posts a Phase 3 result

According to BioPharma Dive on October 7, 2026, Cerevance tested solengepras in 341 participants with Parkinson's disease. The higher dose reduced average daily off time by 0.61 hours versus placebo after 12 weeks.

The same trial also produced a 0.60-hour increase in on time without troublesome dyskinesia, according to BioPharma Dive. Cerevance plans to discuss the next regulatory steps with the U.S. Food and Drug Administration, giving Takeda's neuroscience portfolio an additional development milestone.

Revenue grows as core EPS falls

Takeda's latest reported quarter was Q1 of fiscal year 2026. Revenue increased 10.2 percent to JPY 1.22 trillion on an actual foreign exchange basis, while core revenue declined 0.5 percent at constant exchange rates, according to ScanX.

The earnings mix was less uniform than the headline revenue figure. Core EPS fell 11.8 percent at constant exchange rates to JPY 154, while reported operating profit stood at JPY 201.4 billion in Q1 FY2026, as ScanX reported on September 17, 2026.

October earnings date is set

Takeda is scheduled to report its Q2 fiscal year 2027 results on October 29, 2026, before the U.S. market opens, with a conference call listed for 2:00 a.m. ET, according to MarketBeat. That date gives investors the next formal checkpoint for the pipeline and the financial outlook.

Takeda's market capitalization stood at JPY 9.17 trillion on October 7, while trading volume on the Tokyo Stock Exchange reached 3.22 million shares. The combination of a rising reported revenue base and weaker core EPS leaves product launches and pipeline execution central to the next earnings review.

Takeda stock closes the gap to its yearly high

Takeda stock was last at JPY 5,766 on the Tokyo Stock Exchange on October 7, 2026, up from a prior close of JPY 5,719. The price, market value and scheduled earnings date frame the stock's next test without creating an investment recommendation.